Ai has seemingly touched on all industries, one way or another, and healthcare is no exception. AI has opened up new possibilities for disease prevention, personalised medicine, and improved patient care. Taiwan's leading medical centres, the National Health Research Institute (NHRI) and Chang Gung Memorial Hospital (CGMH), are at the forefront of this , leveraging accelerated computing and generative AI to advance biomedical research and healthcare delivery.
Dr. Hung-Yi Chiou, director of the Institute of Population Health Sciences (IPHS) at NHRI, emphasizes the potential of AI to fundamentally change the approach to disease prevention and treatment. By analysing large datasets, AI enables the development of personalised medicine strategies and early intervention methods that were previously unattainable.
Similarly, Dr. Wen-Jin Cherng at CGMH highlights the promising future of AI in healthcare, stating that it will lead to more accurate diagnoses, better treatment predictions, and faster patient recovery.
NHRI's to the development of large language models tailored specifically for Taiwan's healthcare needs. Dr. Feng-Chi Chen, deputy director of IPHS at NHRI, emphasises the unique challenges posed by traditional Chinese medical records and genomic data, which require localised solutions.
CGMH runs its systems on premises, keeping data within the hospital's infrastructure. This approach also enables faster data processing and reduced latency. Data privacy
From early detection of colorectal cancer via endoscopy to autoimmune disease screening through microscope images and kidney disease prediction using general imaging techniques, the potential for AI application in healthcare is vast.